Inactive Instrument
Eidos Therapeutics, Inc. Stock
Stocks
EIDX
US28249H1041
Biotechnology & Medical Research
| 1 day | -4.85% |
| Manager | Title | Age | Since |
|---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 47 | 01/03/2016 |
Jonathan Fox
PSD | President | 69 | 01/10/2016 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/06/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/01/21 | Tender | Director | 113,325 | 0.2916% | ||
| 26/01/21 | Issuer sale | Director | 25,973 | 0.0668% | ||
| 26/01/21 | Don | Chief Technology Officer | 366,525 | 0.9431% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.85% | -4.63% | - | - | 4.75B | |
| +2.24% | +8.40% | +58.47% | +69.00% | 68.22B | |
| +4.66% | +8.90% | +16.93% | +85.41% | 59.82B | |
| -0.60% | +1.73% | +24.32% | +94.40% | 56.07B | |
| +2.55% | +15.52% | +30.43% | +120.17% | 47.67B | |
| +2.58% | +7.89% | +32.49% | +45.30% | 45.95B | |
| +4.09% | +6.37% | +228.06% | +899.75% | 43.29B | |
| -0.47% | +9.38% | +27.53% | +52.40% | 35.66B | |
| +3.80% | -1.00% | +98.16% | +66.79% | 34.73B | |
| +1.48% | +6.21% | -38.80% | +395.73% | 25.47B | |
| Average | +1.55% | +7.48% | +53.07% | +203.21% | 46B | |
| Weighted average by Cap. | +2.24% | +7.83% | +54.17% | +182.63% |
Employees
-
